http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2749426-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a135a933620c99beab01d4ac785d25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd9210a3ea9c393abdee0903e12c128f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1272
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
filingDate 2010-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffc3064726f4aea31484eab2f9402558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36b45d72b6bb1dbe395585b11275878a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bc05722883d5eeb4a79e4d42559d860
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9acd832846f928c6ddc8c7ab40ff8163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eba5ce5bf933d427e4c0992092586fb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1db1a51ece5fd0e1ffc3dd6ffe9d0e82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b9e5f75dd93165a3b9546db8aba17e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89f1397d996a7b6c083ff4b78c486062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b0307beafdaf314e5f8e641e1416176
publicationDate 2020-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2749426-T3
titleOfInvention Nucleic Acid Administration Methods and Compositions
abstract A lipid particle comprising a first cationic lipid, a second cationic lipid, a neutral lipid, and a PEG lipid capable of reducing aggregation; wherein the first cationic lipid and the second cationic lipid are each independently selected from the following lipids, and quaternized versions thereof,
priorityDate 2009-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467290740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467077647
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467292221

Total number of triples: 30.